Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02822521 · ClinicalTrials.gov registry record · NA
A Novel Mobile App & Population Management System to Manage Rheumatoid Arthritis Flares
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT02822521 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 190 participants.
The verdict
NCT02822521, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
The overall objective of this proposal is to implement a smart phone application (app) + population management system to monitor rheumatoid arthritis (RA) disease activity between scheduled physician office visits. The population management system includes: 1) a web-based dashboard that consolidates incoming patient-reported data using pre-programmed algorithms to identify increases in disease activity, and 2) the population manager, a trained individual who monitors the web-based dashboard and connects patients with their healthcare providers (HCPs). The investigators central hypothesis is that the combined smart phone app + population management system will improve patient satisfaction and management of RA disease activity.
Interventions
- OTHER Mobile Application
- OTHER Population Management System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2016-11 |
| Est. Completion | 2025-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02822521
The ClinicalTrials.gov registry entry for NCT02822521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mobile Application is the first listed.
NCT02822521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02822521 about?
NCT02822521 is a clinical study titled "A Novel Mobile App & Population Management System to Manage Rheumatoid Arthritis Flares". The overall objective of this proposal is to implement a smart phone application (app) + population management system to monitor rheumatoid arthritis (RA) disease activity between scheduled physician office visits. The population management system includes: 1) a web-based dashboard that consolidates...
What is the current status of trial NCT02822521?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2016-11. Estimated completion is 2025-09.
What interventions are being tested in trial NCT02822521?
The interventions under investigation include: Mobile Application (OTHER), Population Management System (OTHER).
Who is sponsoring clinical trial NCT02822521?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.